EUVIMEDEUVIMED entdecken
Crossref

Formulation, Optimization and In-Vivo Characterization of Thermosensitive In-Situ Nasal Gel Loaded with Bacoside a for Treatment of Epilepsy

Someshwar Dattatray Mankar, Shraddha Ranjan Parjane, Suhas Shivaji Siddheshwar, Santosh Bhausaheb Dighe

AAPS PharmSciTech · 2024

DOI: 10.1208/s12249-024-02870-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AAPS PharmSciTech, 2024. Verfasst von Someshwar Dattatray Mankar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, 413736, India. sdmankar655@gmail.com. Hauptthemen laut MEDLINE: Administration, Intranasal, Epilepsy, Gels, Nasal Mucosa. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intranasal route has demonstrated superior systemic bioavailability due to its extensive surface area, the porous nature of the endothelial membrane, substantial blood flow, and circumvention of first-pass metabolism. In traditional medicinal practices, Bacopa monnieri, also known as Brahmi, is known for its benefits in enhancing cognitive functions and potential effects in epilepsy. This study aimed to develop and optimize a thermosensitive in-situ nasal gel for delivering Bacoside A, the principal active compound extracted from Bacopa monnieri. The formulation incorporated Poloxamer 407 as a thermogelling agent and HPMC K4M as the Mucoadhesive polymer. A 32-factorial design approach was employed for Optimization. Among the formulations. F7 exhibited the most efficient Ex-vivo permeation through the nasal mucosa, achieving 94.69 ± 2.54% permeation, and underwent a sol-gel transition at approximately 30.48 °C. The study's factorial design revealed that gelling temperature and mucoadhesive strength were critical factors influencing performance. The potential of in-situ nasal Gel (Optimized Batch-F7) for the treatment of epilepsy was demonstrated in an in-vivo investigation using a PTZ-induced convulsion model. This formulation decreased both the occurrence and intensity of seizures. The optimized formulation F7 showcases significant promise as an effective nasal delivery system for Bacoside A, offering enhanced bioavailability and potentially increased efficacy in epilepsy treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, IntranasalEpilepsyGelsNasal MucosaTriterpenesAnimalsMaleTemperatureSaponinsChemistry, PharmaceuticalBiological AvailabilityRatsPoloxamerAnticonvulsants

Stichwörter der Autor:innen

in-situ nasal gelBacoside AHPMC K4MPoloxamer 407factorial designoptimization

Substanzen

GelsTriterpenesbacoside ASaponinsPoloxamerAnticonvulsants

Autor:innen und Institutionen

  • Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, 413736, India. sdmankar655@gmail.com.
  • Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, 413736, India.

Zitieren

APA

Mankar, S. D., Parjane, S. R., Siddheshwar, S. S., & Dighe, S. B. (2024). Formulation, Optimization and In-Vivo Characterization of Thermosensitive In-Situ Nasal Gel Loaded with Bacoside a for Treatment of Epilepsy. AAPS PharmSciTech. https://doi.org/10.1208/s12249-024-02870-2

Vancouver

Mankar SD, Parjane SR, Siddheshwar SS, Dighe SB. Formulation, Optimization and In-Vivo Characterization of Thermosensitive In-Situ Nasal Gel Loaded with Bacoside a for Treatment of Epilepsy. AAPS PharmSciTech. 2024. doi:10.1208/s12249-024-02870-2

BibTeX
@article{Mankar2024,
  author = {Mankar, Someshwar Dattatray and Parjane, Shraddha Ranjan and Siddheshwar, Suhas Shivaji and Dighe, Santosh Bhausaheb},
  title = {Formulation, Optimization and In-Vivo Characterization of Thermosensitive In-Situ Nasal Gel Loaded with Bacoside a for Treatment of Epilepsy},
  journal = {AAPS PharmSciTech},
  year = {2024},
  doi = {10.1208/s12249-024-02870-2}
}
Kostenlos starten →